These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Very late-onset endocarditis complicated by non-significant aortic regurgitation after device closure of perimembranous ventricular septal defect. Tang C, Zhou K, Hua Y, Wang C. Medicine (Baltimore); 2020 May; 99(19):e20120. PubMed ID: 32384490 [Abstract] [Full Text] [Related]
23. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II]. Zhao PJ, Yu ZQ, Gao W, Li F, Fu LJ, Liu TL, Li Y, Zhang YQ, Huang MR, Guo Y. Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):817-20. PubMed ID: 23302666 [Abstract] [Full Text] [Related]
24. Transcatheter closure of doubly committed subarterial ventricular septal defects with the Amplatzer ductal occluder: initial experience. Huang Y, Yan X, Lu L, Fang J, Sun X, Zhong L, Li J, Chen L. Cardiol Young; 2019 May; 29(5):570-575. PubMed ID: 30968785 [Abstract] [Full Text] [Related]
29. Transcatheter closure of congenital perimembranous ventricular septal defect using the Amplatzer duct occluder 2. Zhao LJ, Han B, Zhang JJ, Yi YC, Jiang DD, Lyu JL. Cardiol Young; 2018 Mar; 28(3):447-453. PubMed ID: 29233213 [Abstract] [Full Text] [Related]
30. Percutaneous closure of ventricular septal defect using LifeTechTM Konar-MF VSD Occluder: initial and short-term multi-institutional results. Sadiq M, Qureshi AU, Younas M, Arshad S, Hyder SN. Cardiol Young; 2022 May; 32(5):755-761. PubMed ID: 34318740 [Abstract] [Full Text] [Related]
31. [Clinical analysis of transcatheter closure of ventricular septal defect with right coronary cusp bulge]. Ji W, Zhang ZF, Shen J, Fu LJ, Shi L, Chen YW, Li F. Zhonghua Er Ke Za Zhi; 2019 Feb 02; 57(2):103-107. PubMed ID: 30695883 [Abstract] [Full Text] [Related]
32. Ventricular septal defect closure in right coronary cusp prolapse and aortic regurgitation complicating VSD in the outlet septum: which treatment is most appropriate? Jian-Jun G, Xue-Gong S, Ru-Yuan Z, Min L, Sheng-Lin G, Shi-Bing Z, Qing-Yun G. Heart Lung Circ; 2006 Jun 02; 15(3):168-71. PubMed ID: 16697257 [Abstract] [Full Text] [Related]
38. Transcatheter closure of perimembranous ventricular septal defects using the amplatzer membranous VSD occluder: immediate and midterm results of an international registry. Holzer R, de Giovanni J, Walsh KP, Tometzki A, Goh T, Hakim F, Zabal C, de Lezo JS, Cao QL, Hijazi ZM. Catheter Cardiovasc Interv; 2006 Oct 02; 68(4):620-8. PubMed ID: 16969878 [Abstract] [Full Text] [Related]
40. Short- and medium-term follow-up of transcatheter closure of perimembranous ventricular septal defects. Li H, Shi Y, Zhang S, Ren Y, Rong X, Wang Z, Xia T, Wu T, Xu H, Yan Y, Zhan Y, Chu M, Wu R. BMC Cardiovasc Disord; 2019 Oct 16; 19(1):222. PubMed ID: 31619172 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]